# LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
> **NDA206040** · New Drug Application · Sponsor: MYLAN LABS LTD · Approved 2014-09-04
## Drug
- **FDA Application Number:** NDA206040
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN LABS LTD
- **First approval:** 2014-09-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206040)
---
*MORVS · CC0 1.0*